Search Results - retina

4 Results Sort By:
Enlarging Attachment for Binocular Indirect Ophthalmoscopy
A retrofittable attachment that provides increased magnification of the back of the eye (the ocular fundus). Background: Indirect ophthalmoscopy is performed by an examiner with the use of a binocular indirect ophthalmoscope (BIO). The examiner uses a headset to view an image of the patient's eye in a condensing lens hand-held by the examiner...
Published: 9/17/2024   |   Inventor(s): David Krumholz
Keywords(s): #SUNYresearch, eye examination, fundus, imaging, medical devices, ophthalmology, ophthalmoscopy, retina, Technologies, vision care
Category(s): Technology Classifications > Imaging, Technology Classifications > Medical Devices, Campus > SUNY College of Optometry
Induced Pluripotent Stem Cells Derived from Patients with CEP290-associated Ciliopathies and Unaffected Family Members
Abstract: Approximately one-third of non-syndromic retinal dystrophies involve a defect in a ciliary protein. Non-syndromic retinal ciliopathies include retinitis pigmentosa, cone dystrophy, cone-rod dystrophy, macular dystrophy, and Leber-congenital amaurosis (LCA). Many CEP290-LCA patients also exhibit auditory and olfactory defects. Induced pluripotent...
Published: 4/8/2024   |   Inventor(s): Anand Swaroop, Hiroko Shimada-Ishii, Yu Holly Chen, Milton English
Keywords(s): Anosmia, Cell therapy, Ciliopathies, Congenital Blindness, Drug Development, GENE THERAPY, hearing loss, iPS, National Eye Institute, NEI, Pluripotent Stem Cells, Primary Cilia, Retina, Retinal degeneration, Swaroop, VISION
Category(s): Application > Research Materials, Collaboration Sought > Licensing, Collaboration Sought > Collaboration, TherapeuticArea > Opthamology, TherapeuticArea > Eye / Ear / Nose / Throat
RP2 and RPGR Vectors For Treating X-linked Retinitis Pigmentosa
Abstract: X-linked forms of retinitis pigmentosa (XLRP) are relatively severe blinding disorders, resulting from progressive photoreceptor dysfunction primarily caused by mutations in RPGR or RP2 gene. This technology is poised to advance RPGR or RP2 gene therapy to clinical stage using AAV8 or AAV9 vector carrying human full-length RPGR or RP2-coding...
Published: 4/8/2024   |   Inventor(s): Zhijian Wu, Anand Swaroop, Suddhasil Mookherjee, Suja Hiriyanna, Tiansen Li
Keywords(s): GENE THERAPY, hereditary ocular disease, Pigmentosa, Retina, Wu
Category(s): TherapeuticArea > Opthamology, TherapeuticArea > Eye / Ear / Nose / Throat, Collaboration Sought > Licensing, Collaboration Sought > Collaboration, Application > Therapeutics
Drug Delivery System for Extended Release of Retinal Drugs
Prolongs Delivery and Release of Drugs for Treating Retinal DiseasesThis drug delivery system delivers ophthalmic drugs that release to the retina over an extended period of time to treat retinal diseases. Diseases of the retina are one of the leading causes of vision loss and cost an estimated $343 billion globally. However, the challenge lies in facilitating...
Published: 6/27/2021   |   Inventor(s): Anuj Chauhan, Russell Macoon
Keywords(s): Device, Drug Delivery (controlled), intravitreal, Medical, Retina, Retinal Degeneration
Category(s): Technology Classifications > Engineering > Chemical, Technology Classifications > Medical Devices > Consumable